(NASDAQ: GUTS) Fractyl Health's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.68%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.35%.
Fractyl Health's earnings in 2025 is -$99,767,000.On average, 3 Wall Street analysts forecast GUTS's earnings for 2025 to be -$74,261,787, with the lowest GUTS earnings forecast at -$80,965,313, and the highest GUTS earnings forecast at -$65,375,718. On average, 3 Wall Street analysts forecast GUTS's earnings for 2026 to be -$56,489,649, with the lowest GUTS earnings forecast at -$69,398,839, and the highest GUTS earnings forecast at -$49,786,124.
In 2027, GUTS is forecast to generate -$42,745,662 in earnings, with the lowest earnings forecast at -$42,745,662 and the highest earnings forecast at -$42,745,662.